Exploring the Potential of CAR T-Cell Therapy in Head and Neck Cancer

May 26, 2017
Sophie Papa, PhD, MBBS, MRCP

Sophie Papa, PhD, MBBS, MRCP, King’s College London in the United Kingdom, discusses chimeric antigen receptor (CAR) T-cell therapy for patients with head and neck cancer.